Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Progression of Relapsing-Remitting Demyelinating Disease Does Not Require Increased TCR Affinity or Epitope Spread.
Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
Care Partners and Multiple Sclerosis: Differential Effect on Men and Women.
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients.
Neuroimaging and genetic correlates of cognitive dysfunction in multiple sclerosis.
Integrated Expression Profiles of mRNA and miRNA in Polarized Primary Murine Microglia.
OCT and Visual Field Changes as Useful Markers for Follow-up of Axonal Loss in Multiple Sclerosis in Egyptian Patients.
Peptide immunotherapy in experimental autoimmune encephalomyelitis.
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis.
Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis.
Correction: Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach.
The substrate of increased cortical FA in MS: A 7T post-mortem MRI and histopathology study.
Production, crystallization and neutron diffraction of fully deuterated human myelin peripheral membrane protein P2.
Review: Effect study of sex hormone in the multiple sclerosis of common neurological disorders.
Retinal ganglion cell layer thinning within one month of presentation for optic neuritis.
Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.
The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease.
Paediatric clinically isolated syndromes: report of seven cases, differential diagnosis and literature review.
[Extending therapeutic possibilities in relapsing-remitting multiple sclerosis: dimethyl fumarate].
Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.
Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.
Adjudin - a Male Contraceptive with Other Biological Activities.
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases.
Importance of Apolipoprotein A-I in Multiple Sclerosis.
Pages
« first
‹ previous
…
634
635
636
637
638
639
640
641
642
…
next ›
last »